Context Therapeutics Inc is trading at $0.91 (-34.68%) following a sharp intraday selloff, though no specific company catalyst has been confirmed to drive the move.
- The significant downward pressure stands out from the broader market, yet the underlying cause remains unclear as no new negative news has been released.
- The decline follows a June 15 report of encouraging interim Phase 1 data for CTIM-76, an announcement that would typically be viewed as a positive development for the stock.